Funding Details
- Awarder
- Inbox
- Date Award
- February 05, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2015
- Founders
- Edgar G. Engleman, MD
- Company Description
- Bolt Biotherapeutics is a private biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of cancer therapeutics. These systemically-administered, tumor-targeted Boltbody™ therapeutics unleash the immune system to induce anti-tumor immunity.
- Market
- Cancer therapeutics
- Location
-
Redwood City,
California,
USA
- Coinvestors
- Nan Fung, Novo Holdings, Vivo Capital
Links